Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating the New Injury Severity Score for blunt trauma patients

Official title: A Prospective Evaluation of the New Injury Severity Score's Accuracy in Blunt Trauma Patients

Run by Al-Nahrain University · NCT06711276 · Data updated 2026-11-12

This study is testing a new scoring system to see if it can better predict how well blunt trauma patients will do after being admitted to the hospital.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment210 (estimated)
SponsorAl-Nahrain University
Academic / other
Locations1 site (Baghdad)
StatusRecruiting
StartedJanuary 10, 2025
Main results expectedJuly 1, 2025
Study endsJuly 15, 2025
Registry record updatedMarch 18, 2025
Trial IDNCT06711276 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults admitted to the emergency department with blunt trauma from incidents such as motor vehicle accidents or falls.

Probably not a fit

Patients under 18 years, pregnant women, or those with unrelated medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the predictive accuracy of the New Injury Severity Score (NISS) in determining mortality outcomes for patients with blunt trauma admitted to the Emergency Department of Kadhimiya Educational Hospital in Iraq. Participants will be evaluated using the NISS score upon admission, and their clinical outcomes, including mortality, need for intensive care, and length of hospital stay, will be monitored throughout their hospitalization. The study seeks to improve trauma management protocols by providing insights into the effectiveness of the NISS in predicting patient outcomes.

Why it matters

Potential benefit: If successful, this study could enhance trauma care by providing a reliable scoring system to predict mortality and resource needs for blunt trauma patients.

How similar studies have gone: While the NISS is a newer scoring system, similar scoring approaches have shown promise in predicting outcomes in trauma patients, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Trauma patients admitted to the emergency department, presenting with blunt trauma, such as from motor vehicle accidents, falls, or assaults.
* Patients with adequate documentation of anatomical injuries and physiological parameters required for NISS calculation.
* Injury assessment and NISS calculation completed within the first 6 hours of arrival to ensure accuracy and consistency in trauma evaluation.

Exclusion Criteria:

* Patients under 18 years, pregnant women, or those with pre-existing medical conditions that may alter trauma scoring accuracy or management outcomes.
* Patients presenting with medical emergencies, terminal illnesses, or conditions unrelated to blunt trauma to ensure focus on trauma-specific evaluations.
* Patients declared dead on arrival or who do not receive active treatment in the emergency department.
* Patients or their families refusing participation or withdrawing consent at any stage of the study.
* Patients transferred from or to another facility or those previously treated elsewhere, as this may affect data collection and scoring reliability.

Where it's running

  • College of Medicine - Al-Nahrain University
    Baghdad, Iraq
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.